APOD is a member of the lipocalin family of proteins, seen in patients with BC; analysis of the relationship between APOD expression and clinical outcome demonstrates significant relevance of the low expression of APOD with a poor overall survival (Diez-Itza et al., 1994). Here, APOD is linked to breast cancer.